Glaukos (GKOS) EBT (2014 - 2026)

Glaukos (GKOS) has reported EBT for 13 consecutive years, with -$17.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 8.7% year-over-year to -$17.7 million in Q2 2026; TTM through Jun 2026 was -$197.4 million, a 109.18% decrease from a year earlier, with the FY2025 full-year figure at -$197.6 million, down 33.69% from the prior year.
• EBT was -$17.7 million for Q2 2026 at Glaukos, up from -$19.3 million in the prior quarter.
• Over five years, EBT peaked at $5.7 million in Q1 2022 and troughed at -$144.4 million in Q4 2025.
• A 5-year average of -$34.6 million and a median of -$31.4 million in 2023 frame the typical range for EBT.
• Across the five-year window, EBT jumped 135.23% in 2022 and slumped 700.12% in 2023, its largest moves.
• Over 5 years, EBT stood at -$34.0 million in 2022, then declined by 20.99% to -$41.2 million in 2023, then climbed by 12.8% to -$35.9 million in 2024, then plunged by 302.02% to -$144.4 million in 2025, then soared by 87.73% to -$17.7 million in 2026.
• The last three EBT figures came in at -$17.7 million (Q2 2026), -$19.3 million (Q1 2026), and -$144.4 million (Q4 2025), per Business Quant data.